Navigation Links
Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus
Date:11/2/2009

Second successful phase III trial points to the first new lupus treatment in over 5O years.

NEW YORK, Nov. 2 /PRNewswire-USNewswire/ -- The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus.

"This is a pivotal moment in lupus research," said Margaret G. Dowd, president of the LRI, an organization that pioneers discovery in lupus. "It demonstrates the power of innovative science to drive discovery and achieve solid clinical results in the complex autoimmune disease of lupus. Benlysta represents new hope for the 1.5 million Americans with lupus and millions more worldwide who have suffered without a safe and effective treatment for more than 50 years."

"This is spectacular news for the world-wide lupus community," said Tammy O. Utset, MD, MPH, an associate professor of medicine at the University of Chicago. "These trials demonstrate that SLE can be studied successfully in a clinical trial setting and should encourage further interest in drug development for lupus, an area of great unmet need. Further, these two large, well-designed trials will allow Benlysta, the first biological agent for the treatment of SLE, to be submitted to the FDA for potential approval."

The trial was the second double-blind, placebo-controlled, multi-center study of Benlysta. Known as BLISS-76, the trial enrolled and randomized 826 patients at 133 clinical sites in 19 countries, primarily in North America and Europe.

"Combining the results of this study with the previous successful BLISS-52 study will yield a very large dataset that will allow a better understanding of lupus, the instruments to measure lupus act
'/>"/>

SOURCE Lupus Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
2. Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9
3. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
4. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
5. Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
6. Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018
7. Promise of a New Lupus Treatment Is a Groundbreaking Achievement
8. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... Houston, Texas (PRWEB) April 23, 2015 ... patient’s True Flow (blood flow through the device) in ... provided by Numerex, the world’s leading provider of Machine ... IoT. , True Flow via VADLink.com ... if there is any drop in flow below a ...
(Date:4/22/2015)... -- Sangamo BioSciences, Inc. (NASDAQ: SGMO ) today reported ... For the first quarter ended March 31, 2015, ... or $0.08 per share, compared to a net loss ... same period in 2014. As of March 31, 2015, ... interest receivable of $226.1 million. Revenues for ...
(Date:4/22/2015)... 22, 2015 Today, DuPont announced ... a leading microbiome discovery company. This acquisition will ... access in both seed and crop protection to ... globally. , “In 2014, the businesses in ... segments sold more than $1 billion in biological ...
(Date:4/22/2015)... Over the last five years, ... growth primarily due to growth in the ... increased nanotechnology R&D expenditure and increased international ... http://www.marketsandmarkets.com/requestCustomization.asp?id=65048077 , In this report, the ... on the basis of products and applications. ...
Breaking Biology Technology:Sangamo BioSciences Reports First Quarter 2015 Financial Results 2Sangamo BioSciences Reports First Quarter 2015 Financial Results 3Sangamo BioSciences Reports First Quarter 2015 Financial Results 4Sangamo BioSciences Reports First Quarter 2015 Financial Results 5Sangamo BioSciences Reports First Quarter 2015 Financial Results 6Sangamo BioSciences Reports First Quarter 2015 Financial Results 7Sangamo BioSciences Reports First Quarter 2015 Financial Results 8DuPont Acquires Taxon Biosciences, Inc. 2DuPont Acquires Taxon Biosciences, Inc. 3DuPont Acquires Taxon Biosciences, Inc. 4Nanotechnology-based Medical Devices Market to Reach Around $8.5 billion by 2019 - Published by MarketsandMarkets 2Nanotechnology-based Medical Devices Market to Reach Around $8.5 billion by 2019 - Published by MarketsandMarkets 3
... API Software, Inc. announced today ... implement the majority of APIs suite of labor ... The solution will include Payrollmation time and attendance, ... human resources software. , ,The hospital is adopting ...
... Network Health Plan , Affinity Health Systems health plan ... today the availability of new online services for NHPs ... Internet-based health management system. , ,NHP will launch the ... member portals. Starting this summer, NHPs providers will be ...
... swing a golf club with one arm, or to write a ... would you? Or, at the very least, progress would be painfully ... human embryonic stem cells, the bodys core cells that can grow ... of embryonic stem cell research have turned out to be much ...
Cached Biology Technology:Lifting federal limits on stem cell research would speed search for cures 2Lifting federal limits on stem cell research would speed search for cures 3
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
(Date:4/14/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® smart ... Design Awards under the category  ,Product Design – Technology,. ... are part of a global multi-disciplinary awards program. The ... marketplace, industry and judging panel. Winners will be announced ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3Synaptics to Report Third Quarter Results on April 23 2
... a landscape susceptible to invasion by alien plant species, ... contributing to the accelerating spread of exotic aquatic species, ... issue of BioScience. John A. Havel of Southwest Missouri ... Vander Zanden of the University of Wisconsin survey evidence ...
... multiple complex biological interactions in a yeast cell in ... the networks of interaction by which components of a ... Open Access journal Journal of Biology shows that such ... predictions about interactions that haven't been observed experimentally. , ...
... just can't tell where you might find love these ... and a social psychologist found love-related neurophysiological systems inside ... responses in the brains of 17 young men and ... madly in love. , The multidisciplinary team found that ...
Cached Biology News:Reservoirs may accelerate the spread of invasive aquatic species, researchers say 2Navigating an integrated yeast network 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 2Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 3Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 4Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 5Love's all in the brain: fMRI study shows strong, lateralized reward, not sex, drive 6
Rabbit polyclonal to GABA A Receptor gamma 2 ( Abpromise for all tested applications). entrezGeneID: 2566 SwissProtID: P18507...
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Anti-GOSR2 Monoclonal AntibodyOther Sub-Family: not assigned-Other Applications: Immunocytochemistry, Immunoprecipitation, Western Blot...
Mouse monoclonal [4A2.2] to SLC6A4 ( Abpromise for all tested applications). entrezGeneID: 6532 SwissProtID: P31645...
Biology Products: